TWO · 6461.TWO
Intech Biopharm Corporation
NT$26.95+NT$0.55 (+2.08%)
Intech Biopharm Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.56% below the high.
Loading market information…
TAI · 4108.TW · TWD
Stock price, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
PhytoHealth Corporation’s quoted price sits in the lower half of its reported 52-week range, 26.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PhytoHealth Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1998 and headquartered in Taipei, Taiwan, PhytoHealth Corporation specializes in the research, development, production, and commercialization of a diverse portfolio including pharmaceutical products, cosmetic lines, specific over-the-counter medications (Class B), and nutritional supplements. Their prominent offerings feature the PG2 Lyophilized injection, specifically designed to alleviate cancer-related fatigue. The company also markets EnerCharge, available both as a formula to boost physical vigor and maintain mental alertness, and as an energy beverage. Another notable product is ReyeasCleanse health food capsules. Furthermore, PhytoHealth extends its expertise to precision medical devices, specialized diagnostic software, and licensing services for computer-aided diagnostic systems.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$26.95+NT$0.55 (+2.08%)
Intech Biopharm Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.56% below the high.
NT$5.22-NT$0.26 (-4.74%)
Medtecs International Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
NT$21.00-NT$0.05 (-0.24%)
Maywufa Company Ltd.’s quoted price sits in the upper half of its reported 52-week range, 5.83% below the high.
NT$5.85-NT$0.09 (-1.52%)
Mercury Biopharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 52.05% below the high.
NT$26.40-NT$0.40 (-1.49%)
Taiwan Bio Therapeutics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.76% below the high.
NT$20.80-NT$0.30 (-1.42%)
Gwo Xi Stem Cell Applied Technology Co. , Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.03% below the high.
NT$22.90-NT$0.10 (-0.43%)
Johnson Chemical Pharmaceutical Works Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.1% below the high.
NT$40.95+NT$0.60 (+1.49%)
Anti-Microbial Savior BioteQ Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 52.93% below the high.
